W
AVNS

WealthCollab’s Avanos Medical AVNS Stock Holding History

WealthCollab’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30
Closed -$430 – 958
2025
Q1 		$430 Sell
30
-154
-84% -$2.4K ﹤0.01% 886
2024
Q4 		$2.93K Hold
184
– – ﹤0.01% 689
2024
Q3 		$4.42K Hold
184
– – ﹤0.01% 640
2024
Q2 		$3.67K Buy
+184
New +$3.58K ﹤0.01% 656

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

WealthCollab's AVNS Position: Q2 2025 in Review

WealthCollab sold out of Avanos Medical (AVNS) in Q2 2025, closing a stake of 30 shares — an estimated $430 sold.

WealthCollab first reported a position in AVNS in Q2 2024 and held it in 4 quarters. The position peaked at $4.42K in Q3 2024. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2025.

  • WealthCollab reported no remaining Avanos Medical position as of Q2 2025 after selling out during the quarter.
  • WealthCollab sold 30 Avanos Medical shares in Q2 2025, an estimated $430.
  • WealthCollab first reported a position in Avanos Medical in Q2 2024 and held it in 4 quarters.
  • WealthCollab's Avanos Medical position peaked at $4.42K in Q3 2024.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2025.

Based on WealthCollab's 13F filing for Q2 2025, filed 15 Aug 2025.